A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease
β Scribed by Brian Feagan; John W. McDonald; Remo Panaccione; Robert A. Enns; Charles N. Bernstein; Terry P. Ponich; Raymond Bourdages; Donald G. MacIntosh; Chrystian Dallaire; Albert Cohen; Richard Fedorak; Pierre Pare; Alain Bitton; Fred Saibil; Frank Anderson; Allan Donner; Cindy J. Wong; Guang Yong Zou; Margaret Vandervoort; Marybeth Hopkins; Gordon R. Greenberg
- Book ID
- 119760434
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 57 KB
- Volume
- 135
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (antiβtumor necrosis factor Ξ± [antiβTNFΞ±] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of β€3 years' duration. ## Methods RA patient